1-20 of 51
Li Zhu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2830: Aurora kinase B phosphorylates ZBP1 to drive PANoptosis following treatment with a combination of PARP and ATR inhibitors

Free
Wenjian Gong, Zhiqi Liao, Shennan Shi, Fan Xiong, Mengshi Luo, Yuewen Zhang, Qiuyang Xu, Yijie Wu, Linghui Wang, Li Zhu, Dong Kuang, Marilyne Labrie, Xuejiao Zhao, Gordon B Mills, Ding Ma, Guangnian Zhao, Qinglei Gao, Yong Fang
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 2830.
https://doi.org/10.1158/1538-7445.AM2025-2830
Published: 21 April 2025
View articletitled, Abstract 2830: Aurora kinase B phosphorylates ZBP1 to drive PANoptosis following treatment with a combination of PARP and ATR inhibitors
Journal Articles

Abstract 403: Characterization of PROTACs for targeting tissue transglutaminase 2 (TG2) in cancer

Free
Andres Felipe Valdivia, Purav Vagadia, Natalia Masnica, Joshua Li Zhu, Vanessa Hernandez, Ana Maria Isac, Gary Schiltz, Daniela Matei
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 403.
https://doi.org/10.1158/1538-7445.AM2025-403
Published: 21 April 2025
View articletitled, Abstract 403: Characterization of PROTACs for targeting tissue transglutaminase 2 (TG2) in cancer
Journal Articles

Abstract PO3-15-01: Overexpression of N-glycosylation related gene OST4 promotes chemotherapy resistance in triple-negative breast cancer

Free
Wei Wang, Deyue Liu, Shuning Ding, Yan Fang, Jiayi Wu, Li Zhu
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO3-15-01.
https://doi.org/10.1158/1538-7445.SABCS23-PO3-15-01
Published: 02 May 2024
View articletitled, Abstract PO3-15-01: Overexpression of N-glycosylation related gene OST4 promotes chemotherapy resistance in triple-negative breast cancer
Journal Articles

Abstract PO5-18-09: Anthracycline-free neoadjuvant therapy with nab-paclitaxel and carboplatin in non-luminal breast cancer: a single-arm phase II trial

Free
Deyue Liu, Li Zhu, Jiayi Wu, Wei Wang, Shuning Ding
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO5-18-09.
https://doi.org/10.1158/1538-7445.SABCS23-PO5-18-09
Published: 02 May 2024
View articletitled, Abstract PO5-18-09: Anthracycline-free neoadjuvant therapy with nab-paclitaxel and carboplatin in non-luminal breast cancer: a single-arm phase II trial
Journal Articles

Abstract 5279: Sequential treatment with PARPi and WEE1i minimizes T cell DNA damage and enhances its immune response

Free
Xiaofei Jiao, Jiahao Liu, Wei Mu, Li Zhu, Xuejiao Zhao, Gordon B. Mills, Qinglei Gao, Yong Fang
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5279.
https://doi.org/10.1158/1538-7445.AM2024-5279
Published: 22 March 2024
View articletitled, Abstract 5279: Sequential treatment with PARPi and WEE1i minimizes T cell DNA damage and enhances its immune response
Journal Articles

Abstract 1482: FKBP52 drives diverse HCC phenotypes through context-dependent targeting of p53

Free
Xing Wang, Jingfeng Wu, Chengyan Tang, Xiang Li, Li Zhu, Yaoyu Liu
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1482.
https://doi.org/10.1158/1538-7445.AM2024-1482
Published: 22 March 2024
View articletitled, Abstract 1482: FKBP52 drives diverse HCC phenotypes through context-dependent targeting of p53
Journal Articles

Abstract 5280: Minimizes T cells DNA damage induced by PARP inhibitors and enhances its anti-tumor efficacy

Free
Jiahao Liu, Xiaofei Jiao, Wei Mu, Huayi Li, Li Zhu, Xuejiao Zhao, Gordon B. Mills, Qinglei Gao, Yong Fang
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5280.
https://doi.org/10.1158/1538-7445.AM2024-5280
Published: 22 March 2024
View articletitled, Abstract 5280: Minimizes T cells DNA damage induced by PARP inhibitors and enhances its anti-tumor efficacy
Journal Articles

Abstract 3997: PARP inhibitors plus anlotinib as bridging therapy for TGFβ-insensitive CAR-T cell therapy targeting MSLN and CD19 in advanced ovarian cancer

Free
Huayi Li, Minghua Xiang, Jiahao Liu, Wei Mu, Li Zhu, Xuejiao Zhao, Gordon B. Mills, Qinglei Gao, Yong Fang
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3997.
https://doi.org/10.1158/1538-7445.AM2024-3997
Published: 22 March 2024
View articletitled, Abstract 3997: PARP inhibitors plus anlotinib as bridging therapy for TGFβ-insensitive CAR-T cell therapy targeting MSLN and CD19 in advanced ovarian cancer
Journal Articles

Abstract 101: A novel humanized mouse model recapitulates the unique TME found in patients with HIV-associated NSCLC

Free
Melani Juric, Gabriel Kaufmann, Li Zhu, Kishu Ranjan, Kriti Agrawal, Barani Kumar Rajendran, Jyothi K. Rajashekar, Hongyu Zhao, Yuval Kluger, Brinda Emu, Kurt A. Schalper, Priti Kumar, Richard A. Flavell, Michael Chiorazzi
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 101.
https://doi.org/10.1158/1538-7445.AM2024-101
Published: 22 March 2024
View articletitled, Abstract 101: A novel humanized mouse model recapitulates the unique TME found in patients with HIV-associated NSCLC
Journal Articles

Abstract 1099: Combined treatment with direct hydrogen peroxide administration and irradiation promotes an abscopal effect in mouse models

Free
Naoya Kemmotsu, Li zhu, Youki Ueda, Hiromichi Dansako, Shinichi Toyooka, Joji Nagasaki, Yosuke Togashi
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1099.
https://doi.org/10.1158/1538-7445.AM2023-1099
Published: 04 April 2023
View articletitled, Abstract 1099: Combined treatment with direct hydrogen peroxide administration and irradiation promotes an abscopal effect in mouse models
Journal Articles

Abstract P4-03-37: The characteristics of male breast cancer by molecular subtypes: a population-based study

Free
Min Wang, Deyue Liu, Li Zhu
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P4-03-37.
https://doi.org/10.1158/1538-7445.SABCS22-P4-03-37
Published: 01 March 2023
View articletitled, Abstract P4-03-37: The characteristics of male breast cancer by molecular subtypes: a population-based study
Journal Articles

Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis

Free
Zheqi Li, Yang Wu, Megan E. Yates, Nilgun Tasdemir, Amir Bahreini, Jian Chen, Kevin M. Levine, Nolan M. Priedigkeit, Azadeh Nasrazadani, Simak Ali, Laki Buluwela, Spencer Arnesen, Jason Gertz, Jennifer K. Richer, Benjamin Troness, Dorraya El-Ashry, Qiang Zhang, Lorenzo Gerratana, Youbin Zhang, Massimo Cristofanilli, Maritza A. Montanez, Prithu Sundd, Callen T. Wallace, Simon C. Watkins, Caterina Fumagalli, Elena Guerini-Rocco, Li Zhu, George C. Tseng, Nikhil Wagle, Jason S. Carroll, Paul Jank, Carsten Denkert, Maria M. Karsten, Jens-Uwe Blohmer, Ben H. Park, Peter C. Lucas, Jennifer M. Atkinson, Adrian V. Lee, Steffi Oesterreich
Journal: Cancer Research
Cancer Res (2022) 82 (7): 1321–1339.
https://doi.org/10.1158/0008-5472.CAN-21-2576
Published: 01 April 2022
View articletitled, Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis
Open the PDF for Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis in another window
Includes: Supplementary data
Journal Articles

Abstract PD1-08: Esr1 mutant breast cancers show elevated basal cytokeratins and immune activation

Free
Zheqi Li, Yang Wu, Olivia Mcginn, Amir Bahreini, Nolan M. Priedigkeit, Kai Ding, Sayali Onkar, Carol A. Sartorius, Lori Miller, Margaret Rosenzweig, Nikhil Wagle, Jennifer K. Richer, William J. Muller, Laki Buluwela, Simak Ali, Dario A.A. Vignali, Yusi Fang, Li Zhu, George C. Tseng, Jason Gertz, Jennifer M. Atkinson, Adrian V. Lee, Steffi Oesterreich
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD1-08.
https://doi.org/10.1158/1538-7445.SABCS21-PD1-08
Published: 15 February 2022
View articletitled, Abstract PD1-08: Esr1 mutant breast cancers show elevated basal cytokeratins and immune activation
Journal Articles

Abstract 2848: Neomorphic cell-cell adhesion reprogramming facilitates metastasis of ESR1 mutant breast cancer

Free
Yang Wu, Zheqi Li, Amir Bahreini, Jian Chen, Ye Qin, Kevin M. Levine, Nilgun Tasdemir, Nolan M. Priedigkeit, Li Zhu, George C. Tseng, Yu Jiang, Benjamin Troness, Laki Buluwela, Simak Ali, Spencer Arnesen, Jason Gertz, Ben Ho Park, Jennifer M. Atkinson, Dorraya El-Ashry, Adrian V. Lee, Steffi Oesterreich
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2848.
https://doi.org/10.1158/1538-7445.AM2021-2848
Published: 01 July 2021
View articletitled, Abstract 2848: Neomorphic cell-cell adhesion reprogramming facilitates metastasis of ESR1 mutant breast cancer
Journal Articles

Abstract PS9-10: Can composite risk model help clinicians make adjuvant ovary function suppression dicision for breast cancer patients

Free
Yue Liang, Xiaosong Chen, Weiqi Gao, Siji Zhu, Jin Hong, Jiayi Wu, Ou Huang, Jianrong He, Li Zhu, Yafen Li, Weiguo Chen, Kunwei Shen
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS9-10.
https://doi.org/10.1158/1538-7445.SABCS20-PS9-10
Published: 15 February 2021
View articletitled, Abstract PS9-10: Can composite risk model help clinicians make adjuvant ovary function suppression dicision for breast cancer patients
Journal Articles

Abstract PS6-39: A novel prognostic nomogram for 2-year survival in HER2-positive patients

Free
Li Zhu, Mengdi Chen, Jiayi Wu
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS6-39.
https://doi.org/10.1158/1538-7445.SABCS20-PS6-39
Published: 15 February 2021
View articletitled, Abstract PS6-39: A novel prognostic nomogram for 2-year survival in HER2-positive patients
Journal Articles

Abstract PS4-28: Efficacy of adjuvant chemotherapy stratified by age and the 21 gene recurrence score in estrogen receptor positive breast cancer

Free
Jing Yu, Caijin Lin, Jiahui Huang, Jin Hong, Weiqi Gao, Siji Zhu, Hui Wang, Ou Huang, Xiaosong Chen, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Kunwei Shen, Jiayi Wu
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS4-28.
https://doi.org/10.1158/1538-7445.SABCS20-PS4-28
Published: 15 February 2021
View articletitled, Abstract PS4-28: Efficacy of adjuvant chemotherapy stratified by age and the 21 gene recurrence score in estrogen receptor positive breast cancer
Journal Articles

Abstract PS17-38: Comprehensive association analysis of 21-gene recurrence score and overweight in breast cancer patients

Free
Yiwei Tong, Weiqi Gao, Jiayi Wu, Siji Zhu, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Kunwei Shen, Xiaosong Chen
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS17-38.
https://doi.org/10.1158/1538-7445.SABCS20-PS17-38
Published: 15 February 2021
View articletitled, Abstract PS17-38: Comprehensive association analysis of 21-gene recurrence score and overweight in breast cancer patients
Journal Articles

Abstract PS18-22: Association of molecular biomarkers heterogeneity and treatment pattern, disease outcomes in multifocal or multicentric breast cancer patients

Free
Shuai Li, Jiayi Wu, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS18-22.
https://doi.org/10.1158/1538-7445.SABCS20-PS18-22
Published: 15 February 2021
View articletitled, Abstract PS18-22: Association of molecular biomarkers heterogeneity and treatment pattern, disease outcomes in multifocal or multicentric breast cancer patients
Journal Articles

Abstract GS1-05: Hotspot ESR1 mutations rewire cell-cell adhesome to facilitate breast cancer metastasis

Free
Zheqi Li, Yang Wu, Amir Bahreini, Jian Chen, Ye Qin, Kevin M. Levine, Nilgun Tasdemir, Nolan Priedigkeit, Li Zhu, George C. Tseng, Yu Jiang, Benjamin Troness, Laki Buluwela, Simak Ali, Spencer Arnesen, Jason Gertz, Ben H. Park, Qiang Zhang, Lorenzo Gerratana, Andrew Davis, Jennifer M. Atkinson, Dorraya El-Ashry, Massimo Cristofanilli, Adrian V. Lee, Steffi Oesterreich
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): GS1-05.
https://doi.org/10.1158/1538-7445.SABCS20-GS1-05
Published: 15 February 2021
View articletitled, Abstract GS1-05: Hotspot ESR1 mutations rewire cell-cell adhesome to facilitate breast cancer metastasis